Norway · Delayed Price · Currency is NOK Oncoinvent ASA Statistics
Total Valuation
Oncoinvent ASA has a market cap or net worth of NOK 211.83 million. The enterprise value is 37.77 million.
| Market Cap | 211.83M |
| Enterprise Value | 37.77M |
Important Dates
The last earnings date was Wednesday, April 22, 2026.
| Earnings Date | Apr 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Oncoinvent ASA has 4.48 million shares outstanding. The number of shares has increased by 396.40% in one year.
| Current Share Class | 4.48M |
| Shares Outstanding | 4.48M |
| Shares Change (YoY) | +396.40% |
| Shares Change (QoQ) | +258.78% |
| Owned by Insiders (%) | 1.27% |
| Owned by Institutions (%) | n/a |
| Float | 3.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.55 |
| PB Ratio | 1.45 |
| P/TBV Ratio | 1.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.24 |
| EV / Sales | 1.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.29 |
Financial Position
The company has a current ratio of 3.23, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.23 |
| Quick Ratio | 3.23 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.03 |
| Interest Coverage | -187.82 |
Financial Efficiency
Return on equity (ROE) is -121.79% and return on invested capital (ROIC) is -74.50%.
| Return on Equity (ROE) | -121.79% |
| Return on Assets (ROA) | -52.64% |
| Return on Invested Capital (ROIC) | -74.50% |
| Return on Capital Employed (ROCE) | -107.71% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 779,694 |
| Profits Per Employee | -4.31M |
| Employee Count | 36 |
| Asset Turnover | 0.15 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 45.60 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 54.00 |
| Average Volume (20 Days) | 5,860 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Oncoinvent ASA had revenue of NOK 28.07 million and -155.07 million in losses. Loss per share was -1.25.
| Revenue | 28.07M |
| Gross Profit | 28.07M |
| Operating Income | -158.33M |
| Pretax Income | -155.07M |
| Net Income | -155.07M |
| EBITDA | -149.80M |
| EBIT | -158.33M |
| Loss Per Share | -1.25 |
Balance Sheet
The company has 177.60 million in cash and 3.55 million in debt, with a net cash position of 174.05 million or 38.87 per share.
| Cash & Cash Equivalents | 177.60M |
| Total Debt | 3.55M |
| Net Cash | 174.05M |
| Net Cash Per Share | 38.87 |
| Equity (Book Value) | 146.32M |
| Book Value Per Share | 0.59 |
| Working Capital | 129.35M |
Cash Flow
In the last 12 months, operating cash flow was -129.87 million and capital expenditures -119,000, giving a free cash flow of -129.99 million.
| Operating Cash Flow | -129.87M |
| Capital Expenditures | -119,000 |
| Depreciation & Amortization | 8.54M |
| Net Borrowing | -2.52M |
| Free Cash Flow | -129.99M |
| FCF Per Share | -29.03 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -564.07% |
| Pretax Margin | -552.46% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Oncoinvent ASA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -396.40% |
| Shareholder Yield | -396.40% |
| Earnings Yield | -73.21% |
| FCF Yield | -61.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 19, 2026. It was a reverse split with a ratio of 0.01.
| Last Split Date | Jan 19, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.01 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |